Twelve Month Follow-Up of CP0108

CompletedOBSERVATIONAL
Enrollment

206

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

April 30, 2016

Conditions
Actinic Keratosis
Interventions
DRUG

Aminolevulinic Acid (ALA)

Levulan PDT given in CP0108

DRUG

Topical Solution Vehicle

Vehicle PDT given in CP0108

DEVICE

BLU-U Blue Light Photodynamic Therapy Illuminator

PDT given in CP0108

Trial Locations (13)

23507

Virginia Clinical Research, Inc., Norfolk

33180

Center for Clinical and Cosmetic Research, Aventura

33609

MOORE Clinical Research, Inc, Brandon

33716

Spencer Clinical Services, St. Petersburg

46032

Shideler Clinical Research Center, Carmel

46168

The Indiana Clinical Trials Center, PC, Plainfield

55432

Minnesota Clinical Study Center, Fridley

60005

Altman Dermatology Associates, Arlington Heights

77056

Suzanne Bruce and Associates, P.A.,The Center for Skin Research, Houston

77845

J&S Studies, Inc, College Station

92122

UCSD Dermatology, San Diego

94538

Center For Dermatology Clinical Research, Inc., Fremont

97210

Oregon Dermatology and Research Center, Portland

Sponsors
All Listed Sponsors
lead

DUSA Pharmaceuticals, Inc.

INDUSTRY

NCT02209012 - Twelve Month Follow-Up of CP0108 | Biotech Hunter | Biotech Hunter